{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:48:10Z","timestamp":1789678090919,"version":"4.0.1"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["SVIN"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p xml:lang=\"en\">\n            The management of antiplatelet medications in neurointerventional procedures remains a subject of considerable variability and debate. This review article explores the diverse clinical practices and the impact of different antiplatelet regimens and platelet activity testing on patient outcomes in neurointerventional treatments. While much of the evidence around antiplatelet therapies largely stems from randomized trials in cardiac and peripheral vascular diseases, their application in neurointerventional settings requires nuanced consideration. Various assays exist to assess individual platelet function, yet the optimal assay, thresholds, and agents remain uncertain due to interpatient variability in medication responsiveness. Expert consensus groups have attempted to standardize antiplatelet management, which is summarized for elective and emergent neurointerventional procedures. Clopidogrel, a commonly used antiplatelet, faces challenges such as genetic variability in metabolism and drug\u2013drug interactions, impacting its effectiveness. Other agents, such as ticagrelor and prasugrel, offer alternatives with different mechanisms of action and potential advantages. Additionally, short\u2010acting intravenous P2Y\n            <jats:sub>12<\/jats:sub>\n            inhibitors, such as cangrelor, and glycoprotein IIb\/IIIa inhibitors provide options for acute bridging therapy in neurointerventional cases. Despite advancements, significant gaps persist in understanding the optimal antiplatelet management for neurovascular procedures. While platelet function testing is commonly used, its clinical utility and standardization remain an area of investigation. This review underscores the need for further multicenter studies to delineate best practices and optimize patient outcomes in neurointerventional settings.\n          <\/jats:p>","DOI":"10.1161\/svin.124.001376","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:49:55Z","timestamp":1721036995000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Antiplatelet Therapy and Platelet Activity Testing for Neurointerventional Procedures"],"prefix":"10.1161","volume":"5","author":[{"given":"Keiko A","family":"Fukuda","sequence":"first","affiliation":[{"name":"Department of Radiology UCLA David Geffen School of Medicine Los Angeles CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Beaman","sequence":"additional","affiliation":[{"name":"Department of Radiology UCLA David Geffen School of Medicine Los Angeles CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-8258","authenticated-orcid":false,"given":"Viktor","family":"Szeder","sequence":"additional","affiliation":[{"name":"Department of Radiology UCLA David Geffen School of Medicine Los Angeles CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-010954"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105800"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3174\/ajnr.A6888","article-title":"Considerations for antiplatelet management of carotid stenting in the setting of mechanical thrombectomy: a Delphi consensus statement","volume":"41","author":"Goyal M","year":"2020","unstructured":"Goyal M, Yoshimura S, Milot G, Fiehler J, Jayaraman M, Dorn F, Taylor A, Liu J, Albuquerque F, Jensen ME, et al. Considerations for antiplatelet management of carotid stenting in the setting of mechanical thrombectomy: a Delphi consensus statement. AJNR Am J Neuroradiol. 2020;41:2274\u20102279.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029132"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12230"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.034"},{"key":"e_1_3_1_8_2","first-page":"123","article-title":"Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel\u2010treated Chinese patients","volume":"19","author":"Zhuo ZL","year":"2018","unstructured":"Zhuo ZL, Xian HP, Long Y, Liu C, Sun YY, Ma YT, Gao H, Zhao JZ, Zhao XT. Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel\u2010treated Chinese patients. Anatol J Cardiol. 2018;19:123\u2010129.","journal-title":"Anatol J Cardiol"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2018.0151"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/1591019921991394","article-title":"P2Y12 inhibitors in neuroendovascular surgery: an opportunity for precision medicine","volume":"27","author":"Rosengart A","year":"2021","unstructured":"Rosengart A, Collins MK, Hendrix P, Uber R, Sartori M, Jain A, Mao J, Goren O, Schirmer CM, Griessenauer CJ. P2Y12 inhibitors in neuroendovascular surgery: an opportunity for precision medicine. Interv Neuroradiol. 2021;27:682\u2010694.","journal-title":"Interv Neuroradiol"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/phar.2228","article-title":"Periprocedural neuroendovascular antiplatelet strategies for thrombosis prevention in clopidogrel\u2010hyporesponsive patients","volume":"39","author":"Barra ME","year":"2019","unstructured":"Barra ME, Berger K, Tesoro EP, Brophy GM. Periprocedural neuroendovascular antiplatelet strategies for thrombosis prevention in clopidogrel\u2010hyporesponsive patients. Pharmacotherapy. 2019;39:317\u2010334.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908077"},{"key":"e_1_3_1_13_2","first-page":"1274","article-title":"Long\u2010term use of ticagrelor in patients with prior myocardial infarction","volume":"373","author":"Bonaca MP","year":"2015","unstructured":"Bonaca MP, Braunwald E, Sabatine MS, Long\u2010term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;373:1274\u20101275.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031149"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-017638"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61170-8"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11237211"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2011.600478"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022125"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/neurintsurg-2018-014396","article-title":"Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single\u2010center pilot study","volume":"11","author":"Aguilar\u2010Salinas P","year":"2019","unstructured":"Aguilar\u2010Salinas P, Agnoletto GJ, Brasiliense LBC, Santos R, Granja MF, Gonsales D, Aghaebrahim A, Sauvageau E, Hanel RA. Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single\u2010center pilot study. J Neurointerv Surg. 2019;11:347\u2010351.","journal-title":"J Neurointerv Surg"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/15910199211015038","article-title":"Glycoprotein IIb\/IIIa inhibitors for the neurointerventionalist","volume":"28","author":"Simonato D","year":"2022","unstructured":"Simonato D, Borchert RJ, Labeyrie M\u2010A, Fuschi M, Thibault L, Henkes H, Fiorella D, Tan BY, Yeo LL, Makalanda HL, et al. Glycoprotein IIb\/IIIa inhibitors for the neurointerventionalist. Interv Neuroradiol. 2022;28:84\u201091.","journal-title":"Interv Neuroradiol"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.07.065"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.21037\/atm-20-7153","article-title":"Clinical importance of testing for clopidogrel resistance in patients undergoing carotid artery stenting\u2010a systematic review","volume":"9","author":"Collette SL","year":"2021","unstructured":"Collette SL, Bokkers RPH, Dierckx RAJO, Van Der Laan MJ, Zeebregts CJ, Uyttenboogaart M. Clinical importance of testing for clopidogrel resistance in patients undergoing carotid artery stenting\u2010a systematic review. Ann Transl Med. 2021;9:1211.","journal-title":"Ann Transl Med"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2013.54.2.288"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-010771"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2006.01.019"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100802317918"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13642"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12376"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta19370"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/cclm-2020-0737","article-title":"Comparison of acetylsalicylic acid and clopidogrel non\u2010responsiveness assessed by light transmittance aggregometry and PFA\u2010100(R) in patients undergoing neuroendovascular procedures","volume":"59","author":"Rolling CC","year":"2020","unstructured":"Rolling CC, Tomada J, Fr\u00f6lich AM, Holst B, Holstein K, Voigtl\u00e4nder M, Janjetovic S, Haddad M, Renn\u00e9 T, Fiehler J, et al. Comparison of acetylsalicylic acid and clopidogrel non\u2010responsiveness assessed by light transmittance aggregometry and PFA\u2010100(R) in patients undergoing neuroendovascular procedures. Clin Chem Lab Med. 2020;59:383\u2010392.","journal-title":"Clin Chem Lab Med"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm226"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.3171\/2017.5.JNS162307"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4388"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2298\/SARH10S1059S","article-title":"Platelet function tests and resistance to antiplatelet therapy","volume":"138","author":"Stegnar M","year":"2010","unstructured":"Stegnar M. Platelet function tests and resistance to antiplatelet therapy. Srp Arh Celok Lek. 2010;138:59\u201063.","journal-title":"Srp Arh Celok Lek"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2021.11.037"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3171\/2017.6.JNS17535","article-title":"Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: comparing results of the VerifyNow P2Y12 assay to thromboelastography with platelet mapping","volume":"129","author":"Corliss BM","year":"2018","unstructured":"Corliss BM, Polifka AJ, Harris NS, Hoh BL, Fox WC. Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: comparing results of the VerifyNow P2Y12 assay to thromboelastography with platelet mapping. J Neurosurg. 2018;129:1160\u20101165.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/2019.12.JNS192396","article-title":"Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping","volume":"134","author":"Corliss BM","year":"2020","unstructured":"Corliss BM, Freedman R, Brennan MM, Smith J, Nerva JD, Harris NS, Polifka AJ, Hoh BL, Fox WC. Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping. J Neurosurg. 2020;134:884\u2010892.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep25478"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2016-012635"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1070"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3405"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamaneurol.2015.0654","article-title":"Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on\u2010treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial","volume":"72","author":"Hwang G","year":"2015","unstructured":"Hwang G, Huh W, Lee JS, Villavicencio JB, Villamor RBV, Ahn SY, Kim J, Chang JY, Park SJ, Park N\u2010M, et al. Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on\u2010treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol. 2015;72:764\u2010772.","journal-title":"JAMA Neurol"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2015-011844"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0818"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2008.00322.x"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2021.10.045"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy395"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.12.047"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.08.032"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2051"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn046"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4623"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.02.016"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117450"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431261","article-title":"Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?","volume":"3","author":"Kass\u2010Hout T","year":"2015","unstructured":"Kass\u2010Hout T, Alderazi YJ, Amuluru K, Jin P, Ayala C, Prestigiacomo C, Gandhi CD. Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do? Interv Neurol. 2015;3:184\u2010189.","journal-title":"Interv Neurol"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000496702","article-title":"Platelet function testing in neurovascular procedures: tool or gimmick?","volume":"8","author":"Cheung NK","year":"2020","unstructured":"Cheung NK, Carr MW, Ray U, Mckenzie D, Froelich JJ. Platelet function testing in neurovascular procedures: tool or gimmick? Interv Neurol. 2020;8:123\u2010134.","journal-title":"Interv Neurol"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2017.1301042"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008410"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024913"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016160542"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.919456"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1703"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.912550"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2014.01.068"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2010.48.4.319"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3955"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2016.07.044"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezx334"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209979"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.290"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.02.026"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-010699"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1177\/0897190017729524"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy002"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.015308"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2012-010334"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016994"},{"key":"e_1_3_1_80_2","first-page":"681","article-title":"Comparison of prasugrel and clopidogrel used as antiplatelet medication for endovascular treatment of unruptured intracranial aneurysms: a meta\u2010analysis","volume":"40","author":"Cagnazzo F","year":"2019","unstructured":"Cagnazzo F, Perrini P, Lefevre P\u2010H, Gascou G, Dargazanli C, Riquelme C, Derraz I, Di Carlo D, Bonafe A, Costalat V. Comparison of prasugrel and clopidogrel used as antiplatelet medication for endovascular treatment of unruptured intracranial aneurysms: a meta\u2010analysis. Am J Neuroradiol. 2019;40:681\u2010686.","journal-title":"Am J Neuroradiol"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12714"},{"key":"e_1_3_1_82_2","first-page":"1856","article-title":"Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms","volume":"27","author":"Yi HJ","year":"2006","unstructured":"Yi HJ, Gupta R, Jovin TG, Tayal A, Genevro J, Gologorsky Y, Horowitz M, Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol. 2006;27:1856\u20101860.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-014-1452-x"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.09.011"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300815"},{"key":"e_1_3_1_86_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1591019920936923","article-title":"Cangrelor dose titration using platelet function testing during cerebrovascular stent placement","volume":"27","author":"Entezami P","year":"2021","unstructured":"Entezami P, Holden DN, Boulos AS, Paul AR, Field NC, Nourollahzadeh E, Yamamoto J, Dalfino JC. Cangrelor dose titration using platelet function testing during cerebrovascular stent placement. Interventional Neuroradiol. 2021;27:88\u201098.","journal-title":"Interventional Neuroradiol"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-021-00491-9"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3418"},{"key":"e_1_3_1_89_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3174\/ajnr.A3621","article-title":"Last\u2010recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device","volume":"35","author":"Delgado Almandoz JE","year":"2014","unstructured":"Delgado Almandoz JE, Crandall BM, Scholz JM, Fease JL, Anderson RE, Kadkhodayan Y, Tubman DE. Last\u2010recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device. Am J Neuroradiol. 2014;35:128\u2010135.","journal-title":"Am J Neuroradiol"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03020.x"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031164"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.3171\/2017.5.JNS162663"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy341"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2015-011727"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2111749"},{"key":"e_1_3_1_96_2","doi-asserted-by":"crossref","first-page":"20085","DOI":"10.18632\/aging.103452","article-title":"Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA","volume":"12","author":"Yang Y","year":"2020","unstructured":"Yang Y, Chen W, Pan Y, Yan H, Meng X, Liu L, Wang Y, Wang Y. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA. Aging (Albany NY). 2020;12:20085\u201320094.","journal-title":"Aging (Albany NY)"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-021-02386-7"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2012-010302"},{"key":"e_1_3_1_99_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1591019916669090","article-title":"Prasugrel versus clopidogrel in stent\u2010assisted coil embolization of unruptured intracranial aneurysms","volume":"23","author":"Sedat J","year":"2017","unstructured":"Sedat J, Chau Y, Gaudart J, Sachet M, Beuil S, Lonjon M. Prasugrel versus clopidogrel in stent\u2010assisted coil embolization of unruptured intracranial aneurysms. Interv Neuroradiol. 2017;23:52\u201359.","journal-title":"Interv Neuroradiol"}],"container-title":["Stroke: Vascular and Interventional Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/SVIN.124.001376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T08:02:49Z","timestamp":1736582569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/SVIN.124.001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1161\/SVIN.124.001376"],"URL":"https:\/\/doi.org\/10.1161\/svin.124.001376","relation":{},"ISSN":["2694-5746"],"issn-type":[{"value":"2694-5746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-02-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e001376"}}